Medifocus, Inc. TSXV MFS, OTC MDFZF is a leader in the use of focused microwave energy to treat cancer and other tumors. It owns two fully developed technology platforms with comprehensive US and international patent protection: The Endo thermotherapy Platform a catheter basis focused heat technology platform that utilizes natural body openings to deliver precise microwave thermotherapy to the diseased sites. The U.S. FDA approved Prolieve Thermodilatation System for the treatment of Benign Prostatic Hyperplasia BPH was developed based on the Endo thermotherapy and is currently generating revenue, and The Adaptive Phased Array APA Microwave Focusing Platform invented by MIT, licensed to Medifocus, directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The Company s APA Breast Cancer Treatment System, developed from the APA technology platform has received approval from the U.S. FDA and Health Canada to conduct the pivotal Phase III clinical trials. The Company believes that these two technology platforms can provide the design basis for the development of multiple cancer treatment systems for surface, subsurface and deep seated localized and regional cancers.
Quote | Medifocus Inc (OTCMKTS:MDFZF)
Last: | $0.0001 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0001 |
Close: | $0.0001 |
High: | $0.0001 |
Low: | $0.0001 |
Volume: | 540,000 |
Last Trade Date Time: | 12/15/2021 04:54:38 pm |
News | Medifocus Inc (OTCMKTS:MDFZF)
TORONTO, ON and COLUMBIA, MD / ACCESSWIRE / May 12, 2022 / Medifocus, Inc. (OTC PINK:MDFZF) and (TSXV:MFS.H.APH) ("Medifocus" or the "Company") a biotechnology company holding a portfolio of medical products encompassing thermotherapy systems used in treating cancerous and benign tumors and ...
TORONTO, ON / ACCESSWIRE / September 17, 2021 / Medifocus, Inc. (OTC PINK:MDFZF) and (TSXV:MFS.H.APH) (" Medifocus " or the " Company ") a biotechnology company holding a portfolio of medical products encompassing thermotherapy systems used in treating cancerous and benign tumors and enlarge...
Message Board Posts | Medifocus Inc (OTCMKTS:MDFZF)
Subject | By | Source | When |
---|---|---|---|
MDFZF SEC Admin. Proceeding for severely delinquent Financials: | Renee | investorshub | 04/24/2023 9:33:51 PM |
i take it this company is as dead | rakp | investorshub | 01/24/2021 8:23:11 AM |
lol man I made my money and moved | Oliverjack | investorshub | 10/18/2020 3:34:48 AM |
That was 183 days ago, anything new since | rakp | investorshub | 10/17/2020 11:04:11 AM |
they ar estill working hard this will run | Oliverjack | investorshub | 04/15/2020 5:10:30 PM |
News, Short Squeeze, Breakout and More Instantly...
TORONTO, ON and COLUMBIA, MD / ACCESSWIRE / May 12, 2022 / Medifocus, Inc. (OTC PINK:MDFZF) and (TSXV:MFS.H.APH) ("Medifocus" or the "Company") a biotechnology company holding a portfolio of medical products encompassing thermotherapy systems used in treating cancerous and benign tumors and ...
TORONTO, ON / ACCESSWIRE / September 17, 2021 / Medifocus, Inc. (OTC PINK:MDFZF) and (TSXV:MFS.H.APH) (" Medifocus " or the " Company ") a biotechnology company holding a portfolio of medical products encompassing thermotherapy systems used in treating cancerous and benign tumors and enlarge...
Columbia, Maryland and Toronto, Ontario--(Newsfile Corp. - August 29, 2019) - Medifocus, Inc. (OTCQB: MDFZF) (TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic H...